Corilagin has anti-inflammatory activity. Corilagin has a significant antitumour potential and lower toxicity in normal cells in vitro.Corilagin can enhance the cytotoxicity of both cisplatin and doxorubicin on the Hep3B hepatoma cells.Corilagin has antiviral activity, reduces the cytotoxicity induced by EV71 or CA16 on Vero cells with and IC50 value of 5.6 and 32.33 μg/mL, respectively. Corilagin shows the potential to protect against HSV-1-induced encephalitis, and the beneficial effects may be mediated by inhibiting TLR2 signaling pathways.Corilagin has antifibrotics property and is potentiated in treating idiopathic pulmonary fibrosis(IPF), attenuates bleomycin-induced epithelial injury and fibrosis via inactivation of oxidative stress, proinflammatory cytokine release and NF-κB and TGF-β1 signaling. Solvent:Pyridine, Methanol, Ethanol, etc.
产品名:Corilagin
货号:orb1303736
产品中文名:Corilagin
产品详情链接:https://www.biorbyt.com.cn/corilagin-orb1303736.html 武汉博欧特生物科技有限公司(www.biorbyt.com.cn )为英国品牌Biorbyt(www.biorbyt.com )中国区总代理。负责biorbyt品牌产品在中国市场的推广、销售及售后服务。为您提供各种biorbyt原装进口产品,主推四大类: